These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 9700674)
21. Cerebrolysin in mild-to-moderate Alzheimer's disease: a meta-analysis of randomized controlled clinical trials. Gauthier S; Proaño JV; Jia J; Froelich L; Vester JC; Doppler E Dement Geriatr Cogn Disord; 2015; 39(5-6):332-47. PubMed ID: 25832905 [TBL] [Abstract][Full Text] [Related]
22. Nerve growth factor and nootropic drug Cerebrolysin but not fibroblast growth factor can reduce spatial memory impairment elicited by fimbria-fornix transection: short-term study. Francis-Turner L; Valousková V Neurosci Lett; 1996 Jan; 202(3):193-6. PubMed ID: 8848264 [TBL] [Abstract][Full Text] [Related]
23. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke. Lang W; Stadler CH; Poljakovic Z; Fleet D; Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193 [TBL] [Abstract][Full Text] [Related]
24. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial. Ladurner G; Kalvach P; Moessler H; J Neural Transm (Vienna); 2005 Mar; 112(3):415-28. PubMed ID: 15583955 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin. Alvarez XA; Cacabelos R; Sampedro C; Aleixandre M; Linares C; Granizo E; Doppler E; Moessler H Eur J Neurol; 2011 Jan; 18(1):59-68. PubMed ID: 20500802 [TBL] [Abstract][Full Text] [Related]
26. The hyperventilation-induced ischaemia model in human neuropharmacology: neurophysiological and psychometric studies of aniracetam and 3-OH aniracetam. Kraaier V; van Huffelen AC; Wieneke GH Eur J Clin Pharmacol; 1989; 36(6):605-11. PubMed ID: 2776818 [TBL] [Abstract][Full Text] [Related]
27. [Treatment and prevention of cognitive dysfunction in patients with arterial hypertension and atherosclerosis: results of a randomized double-blind placebo-controlled trial of cerebrolysin]. Vereshchagin NV; Suslina ZA; Timerbaeva SL; Kashina EM; Gnezditskiĭ VV; Maksimova MIu; Rebrova OIu; Smirnova IN Ter Arkh; 2001; 73(4):22-7. PubMed ID: 11494441 [TBL] [Abstract][Full Text] [Related]
28. Electroencephalographic and psychomotor effects of chlorpromazine and risperidone relative to placebo in normal healthy volunteers. Hughes AM; Lynch P; Rhodes J; Ervine CM; Yates RA Br J Clin Pharmacol; 1999 Sep; 48(3):323-30. PubMed ID: 10510142 [TBL] [Abstract][Full Text] [Related]
29. Meta-analysis: the efficacy of nootropic agent Cerebrolysin in the treatment of Alzheimer's disease. Wei ZH; He QB; Wang H; Su BH; Chen HZ J Neural Transm (Vienna); 2007; 114(5):629-34. PubMed ID: 17318304 [TBL] [Abstract][Full Text] [Related]
30. [Short-term effects of septo-hippocampal pathway transsection and cerebrolysin effects on glutathione-related enzymes in the rat brain]. Cruz R; Francis L; Díaz-Suárez CM; González-Fraguela ME Rev Neurol; 1998 Apr; 26(152):551-4. PubMed ID: 9796003 [TBL] [Abstract][Full Text] [Related]
31. The drug cerebrolysin and its peptide fraction E021 increase the abundance of the blood-brain barrier GLUT1 glucose transporter in brains of young and old rats. Gschanes A; Boado R; Sametz W; Windisch M Histochem J; 2000 Feb; 32(2):71-7. PubMed ID: 10816070 [TBL] [Abstract][Full Text] [Related]
32. Decrease in short-term memory function induced by CCK-4 in healthy volunteers. Shlik J; Koszycki D; Bradwejn J Peptides; 1998; 19(6):969-75. PubMed ID: 9700743 [TBL] [Abstract][Full Text] [Related]
33. [Experience with using high doses of cerebrolysin in vascular dementia]. Iakhno NN; Damulin IV; Zakharov VV; Levin OS; Elkin MN Ter Arkh; 1996; 68(10):65-9. PubMed ID: 9026950 [TBL] [Abstract][Full Text] [Related]
34. Effects of tiapride on electroencephalograms and cognitive functions in the elderly. Patat A; Alberini H; Bonhomme D; Soubrane C; Allain H; Gandon JM Int Clin Psychopharmacol; 1999 Jul; 14(4):199-208. PubMed ID: 10468312 [TBL] [Abstract][Full Text] [Related]
35. Effects of 50mg amisulpride on EEG, psychomotor and cognitive functions in healthy sleep-deprived subjects. Patat A; Rosenzweig P; Miget N; Allain H; Gandon JM Fundam Clin Pharmacol; 1999; 13(5):582-94. PubMed ID: 10520732 [TBL] [Abstract][Full Text] [Related]
36. Effect of zopiclone and temazepam on sleep EEG parameters, psychomotor and memory functions in healthy elderly volunteers. Hemmeter U; Müller M; Bischof R; Annen B; Holsboer-Trachsler E Psychopharmacology (Berl); 2000 Jan; 147(4):384-96. PubMed ID: 10672632 [TBL] [Abstract][Full Text] [Related]
37. Steady state visually evoked potential (SSVEP) topography changes associated with cocoa flavanol consumption. Camfield DA; Scholey A; Pipingas A; Silberstein R; Kras M; Nolidin K; Wesnes K; Pase M; Stough C Physiol Behav; 2012 Feb; 105(4):948-57. PubMed ID: 22120044 [TBL] [Abstract][Full Text] [Related]